2015 | Charlie G. Buffie1,2, Vanni Bucci9, Richard R. Stein5, Peter T. McKenney1,2, Lilan Ling2,7, Asia Gobourne2,7, Daniel No2,7, Hui Liu8, Melissa Kinnebrew1,2, Agnes Viale6, Eric Littmann2, Marcel R. M. van den Brink3,4, Robert R. Jenq3, Ying Taur1,2, Chris Sander5, Justin Cross8, Nora C. Toussaint2, Joao B. Xavier2,5, and Eric G. Pamer1,2,4
A study published in Nature (2015) investigates the role of the intestinal microbiome in resistance to Clostridium difficile (C. difficile) infection. The research identifies specific bacterial species, particularly Clostridium scindens, which contribute to resistance by modulating bile acid metabolism. The study shows that C. scindens, a bile acid 7-dehydroxylating bacterium, enhances resistance to C. difficile infection through the production of secondary bile acids. This finding has implications for the development of microbiome-based therapies and diagnostics for individuals at risk of C. difficile infection. The study used a combination of mouse models, clinical studies, metagenomic analyses, and mathematical modeling to identify and validate the role of specific bacterial species in infection resistance. The research highlights the importance of the microbiome in maintaining health and preventing infections, and suggests that restoring the microbiome through targeted interventions could be a promising approach for treating C. difficile infections. The study also emphasizes the need for further research into the mechanisms by which the microbiome influences infection resistance and the potential for developing microbiome-based therapies.A study published in Nature (2015) investigates the role of the intestinal microbiome in resistance to Clostridium difficile (C. difficile) infection. The research identifies specific bacterial species, particularly Clostridium scindens, which contribute to resistance by modulating bile acid metabolism. The study shows that C. scindens, a bile acid 7-dehydroxylating bacterium, enhances resistance to C. difficile infection through the production of secondary bile acids. This finding has implications for the development of microbiome-based therapies and diagnostics for individuals at risk of C. difficile infection. The study used a combination of mouse models, clinical studies, metagenomic analyses, and mathematical modeling to identify and validate the role of specific bacterial species in infection resistance. The research highlights the importance of the microbiome in maintaining health and preventing infections, and suggests that restoring the microbiome through targeted interventions could be a promising approach for treating C. difficile infections. The study also emphasizes the need for further research into the mechanisms by which the microbiome influences infection resistance and the potential for developing microbiome-based therapies.